Navigation Links
Albumin (BCP-DIMENSION)

ProductsAlbumin (BCP-DIMENSION)
Company Randox Laboratories Ltd.
Item Albumin (BCP-DIMENSION)
Features 
Description The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum
Info Randox Laboratories Ltd.
Customer Service: 44 (0) 28 9442 2413
Web site: http://www.randox.com/

Related medicine products :

1. Albumin Reagent
2. Albumin
3. Albumin Reagent Set
4. Albumin FS
5. Albumin (BCG)
6. Albumin (BCP)
7. Albumin, Serum or Plasma by Spectrophotometry
8. Albumin, Body Fluid
9. Albumin, CSF
10. Albumin, Glycated
11. Albumin, Serum by Nephelometry
Lyphochek Hypertension Markers Control is a trilevel control designed to monitor the performance of testing procedures for renin and other analytes associated with hypertension disorders.
Lyphochek Immunology Plus Control is an assayed control for monitoring chemistry procedures that test for autoimmune, anemic, malignant, hepatic and nephrotic-disease states. Available in two levels.
The Acceava pregnancy urine dipstick test provides qualitative determination of human chorionic gonadatropin in urine for early detection of pregnancy.
The Acceava Trichomonas Rapid Test is an immunochromatographic assay that detects pathogen antigens directly from vaginal swabs. Results are rapid, occurring within approximately 10 minutes.
Medicine Products:
(Date:12/1/2008)...wire/ -- Including a patient,s photo with imaging ...from the radiologist interpreting the images, as w...cording to a study presented today at the annual m...a (RSNA). , , "Our study emphasizes approa...nonymous case study," said lead author Yehonatan N...
(Date:12/1/2008)... research reveals that computed tomography (CT) co... the potential to screen for two diseases at once-... commonly affect adults over age 50. Results of th...ing of the Radiological Society of North America (...ion to screening for colorectal cancer, we were ab...
(Date:12/1/2008)...ile many Americans are,struggling to cope amid gr...f,basic necessities, unemployment and home forecl...anded Rx Outreach to help lower-income consumers g... http://www.newscom.com/cgi-bin/prnh/20080827/EXP...can now receive a six-month supply of their,presc...
(Date:12/1/2008)...aging exam results may enable a more meticulous re..., as well as a more personal and empathetic approa...nual meeting of the Radiological Society of North ...hing the patient as a human being and not as an an... Turner, M.D., radiology resident at Shaare Zedek ...
Breaking Medicine News(10 mins):Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3Health News:CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis 2Health News:CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis 3Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 2Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 3Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 4Health News:Patient photos spur radiologist empathy and eye for detail 2
...ia's leading telecom companies, said Wednesday it ...ospitals to provide telemedicine services in over ...als will leverage Reliance Infocomm's nationwide c...stores in 105 cities to offer high-quality healthc...
...that seem to be effective in prevent the brain dam...iversity of South Florida have found that a compon...age in the brains of mice genetically programmed t...se process. The component, called epigallocatechin...
...onsumption of walnuts can boost blood levels of m...hormone that is naturally produced in humans by th...h // inducing and regulating sleep, since it is pr...searchers investigated whether melatonin is presen...
...ommon cancer affecting men and occurs in men 65 ye... of 50 years should undergo the routine examinatio...state Specific Antigen, by monitoring the levels o...a family history of the disease should begin regul...
Other Medicine News:
(Date:11/28/2008)... Eli Lilly and Company,(...rug Application (sNDA) from,the U.S. Food and Dru... HCl),for the management of chronic pain. Lilly p...f of 2009, adding data from a recently completed p...he knee. , The decision does not affect dul...
(Date:11/26/2008)...density, automation and intelligent clinical appli...an all new level , , CHICAGO, Ill., Nov. 26...( www.siemens.com/healthcare ) highlights the ACU...S)(1), the world,s first multi-use, automated vol...ic Assembly and Annual Meeting of the Radiological...
(Date:11/25/2008)...25 Kleinert Kutz and U...he fifth U.S. hand transplant on Messina, New York...wish Hospital Hand Care Center on Monday, November...nd was completed shortly after 9 p.m. in a record ...m.com/cgi-bin/prnh/20081125/DC48555-a ) , (Phot...
(Date:11/25/2008)...alif., Nov. 25 Poniard,...maceutical company focused on,innovative oncology...ing,strategic alternatives for its preclinical re...focus its resources on the clinical development of...upport the initial commercialization of,picoplati...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Closeness is not a problem 3A New ways to handle spatial dependencies in species distributions 1308 1The Advisory Board Company to Present at CIBC World Markets Mid 26 Small Cap Best Ideas Conference 6794 1Susan G Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 6791 1Susan G Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 6791 2Abbott Employees Give Back to Local Communities This Holiday Season 6788 1Abbott Employees Give Back to Local Communities This Holiday Season 6788 2Abbott Employees Give Back to Local Communities This Holiday Season 6788 3
...WIRE)--Apr 10, 2007 - The two most,prevalent forms...,syndromes, may share a common cause, according to...cine. The problem, a crippled,communication networ...., Although the genetics of the disorders are very...be the same, said Daniel Madison,PhD, associate p...
... Patient Tolerance Support Development,of Omega DU... April 12, 2007 /PRNewswire/ -- Intarcia,Therapeut...any,today announced final results from a Phase 2 ...n in treatment-naive patients,with genotype 1 chro...a interferon in combination with ribavirin is well...
Other Medicine Technology:Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 2Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 3Fragile X, Down Syndromes Linked to Faulty Brain Communication,Stanford Researcher Finds 4Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4